Article Text
Statistics from Altmetric.com
The Medicines and Healthcare products Regulatory Agency has recently circulated a Drug Safety Update regarding the risk of serious adverse events following the use of intravenous hyoscine butylbromide (Buscopan) in patients with underlying cardiac disease.1
Buscopan is commonly used during endoscopic procedures. It induces smooth muscle relaxation and reduces spasm in the gastrointestinal tract. It is used during upper gastrointestinal endoscopy and small bowel enteroscopy to reduce contraction and aid mucosal visualisation.2 During endoscopic retrograde cholangiopancreatography, it is used to facilitate access to the common bile duct during cannulation of the ampulla of Vater.3 During colonoscopy, it is …
Footnotes
Contributors CR conceived the idea for the article. TJWL wrote the original draft. All authors contributed to the intellectual content and editing of the document.
Competing interests None declared
Provenance and peer review Not commissioned; internally peer reviewed.
Data sharing statement No source data to share.